NPM1-ALK- and p-STAT3-dependent IRF4 gene expression

Stable Identifier
R-HSA-9851117
Type
Reaction [omitted]
Species
Homo sapiens
Compartment
nucleoplasm, cytosol
ReviewStatus
5/5
Locations in the PathwayBrowser
Expand all
General
SVG | 
PNG
Low
Medium
High
 | PPTX  | SBGN
NPM1-ALK- and p-STAT3-dependent IRF4 gene expression
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
STAT3 binds to the IRF4 promoter downstream of NPM-ALK to promote IRF4 gene expression (Bandini et al, 2018; Marzec et al, 2013; Piva et al, 2010; Kasprzycka et al, 2006; Durant et al, 2010). IRF4 is a member of the interferon regulatory factor family of transcription factors that is expressed in immune cells response to activation of T-cell or B-cell receptors, IL-4 and CD40 signaling (reviewed in Wong et al, 2022). IRF4 expression downstream of NPM-ALK signaling is required for proliferation and survival, possibly through induction of MYC gene expression (Bandini et al, 2018; Weilemann et al, 2015).
Literature References
PubMed ID Title Journal Year
24218456 Malignant transformation of CD4+ T lymphocytes mediated by oncogenic kinase NPM/ALK recapitulates IL-2-induced cell signaling and gene expression reprogramming

Marzec, M, Halasa, K, Liu, X, Wang, HY, Cheng, M, Baldwin, D, Tobias, JW, Schuster, SJ, Woetmann, A, Zhang, Q, Turner, SD, Ødum, N, Wasik, MA

J Immunol 2013
20159827 Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms

Piva, R, Agnelli, L, Pellegrino, E, Todoerti, K, Grosso, V, Tamagno, I, Fornari, A, Martinoglio, B, Medico, E, Zamo, A, Facchetti, F, Ponzoni, M, Geissinger, E, Rosenwald, A, Müller-Hermelink, HK, De Wolf-Peeters, C, Piccaluga, PP, Pileri, S, Neri, A, Inghirami, G

J Clin Oncol 2010
20493732 Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis

Durant, L, Watford, WT, Ramos, HL, Laurence, A, Vahedi, G, Wei, L, Takahashi, H, Sun, HW, Kanno, Y, Powrie, F, O'Shea, JJ

Immunity 2010
16766651 Nucleophosmin/anaplastic lymphoma kinase (NPM/ALK) oncoprotein induces the T regulatory cell phenotype by activating STAT3

Kasprzycka, M, Marzec, M, Liu, X, Zhang, Q, Wasik, MA

Proc Natl Acad Sci U S A 2006
25359993 Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphoma

Weilemann, A, Grau, M, Erdmann, T, Merkel, O, Sobhiafshar, U, Anagnostopoulos, I, Hummel, M, Siegert, A, Hayford, C, Madle, H, Wollert-Wulf, B, Fichtner, I, Dörken, B, Dirnhofer, S, Mathas, S, Janz, M, Emre, NC, Rosenwald, A, Ott, G, Lenz, P, Tzankov, A, Lenz, G

Blood 2015
36077849 IRF4 as an Oncogenic Master Transcription Factor

Wong, RWJ, Ong, JZL, Theardy, MS, Sanda, T

Cancers (Basel) 2022
29346274 IRF4 Mediates the Oncogenic Effects of STAT3 in Anaplastic Large Cell Lymphomas

Bandini, C, Pupuleku, A, Spaccarotella, E, Pellegrino, E, Wang, R, Vitale, N, Duval, C, Cantarella, D, Rinaldi, A, Provero, P, Di Cunto, F, Medico, E, Bertoni, F, Inghirami, G, Piva, R

Cancers (Basel) 2018
Participants
Input
Output
Participates
as an event of
This event is regulated
Positively by
Regulator
pY705, S727-STAT3 dimer:IRF4 gene [nucleoplasm] (Homo sapiens)
Active Unit
p-Y705,S727-STAT3 dimer [nucleoplasm]
Disease
Name Identifier Synonyms
anaplastic large cell lymphoma DOID:0050744
cancer DOID:162 malignant tumor, malignant neoplasm, primary cancer
Cross References
Mondo
Authored
Rothfels, K  (2023-10-14)
Reviewed
Turner, S  (2023-11-08)
Created
Rothfels, K  (2023-10-12)
Cite Us!